申请人:ELI LILLY AND COMPANY
公开号:EP0606723A1
公开(公告)日:1994-07-20
This invention provides the use of certain tetra-substituted imidazolidin-2-one derivatives of formula (I) in the treatment of susceptible neoplasms in mammals. Also provided are certain novel tetra-substituted imidazolidin-2-one derivatives, pharmaceutical formulations employing them and processes for preparing them.
本发明提供了某些式(I)四取代咪唑烷-2-酮衍生物在治疗哺乳动物易感肿瘤中的用途。本发明还提供了某些新型四取代咪唑烷-2-酮衍生物、使用这些衍生物的药物制剂以及制备这些衍生物的工艺。